Concepedia

Publication | Closed Access

Ultra-High-Dose Lanreotide Treatment in Patients with Metastatic Neuroendocrine Gastroenteropancreatic Tumors

DOI

117

Citations

24

References

1999

Year

Siegbert Faiss, U. Räth, Ulrich Mansmann, D. Caird, Norbert Clemens, E. O. Riecken, Bertram Wiedenmann
Digestion

Abstract

Our data show that ultra-high-dose lanreotide treatment in patients with metastatic GEP NET can lead to control of both symptoms and proliferation in at least some patients refractory to conventional therapies.

References

YearCitations

Page 1